Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-08T21:21:27.907Z Has data issue: false hasContentIssue false

Application of NMR-based metabonomics suggests a relationship between betaine absorption and elevated creatine plasma concentrations in catheterised sows

Published online by Cambridge University Press:  28 September 2011

Christian Clement Yde*
Affiliation:
Department of Animal Science, Faculty of Science and Technology, Aarhus University, 8830Tjele, Denmark Department of Food Science, Faculty of Science and Technology, Aarhus University, 5792Aarslev, Denmark
Johan A. Westerhuis
Affiliation:
Biosystems Data Analysis, Faculty of Sciences, University of Amsterdam, 1018WV Amsterdam, The Netherlands
Hanne Christine Bertram
Affiliation:
Department of Food Science, Faculty of Science and Technology, Aarhus University, 5792Aarslev, Denmark
Knud Erik Bach Knudsen
Affiliation:
Department of Animal Science, Faculty of Science and Technology, Aarhus University, 8830Tjele, Denmark
*
*Corresponding author: Dr C. C. Yde, email christianc.yde@agrsci.dk
Rights & Permissions [Opens in a new window]

Abstract

The objective of the present explorative study was to determine the absorption dynamics when feeding diets varying in types and levels of dietary fibre in a catheterised animal model. A total of six sows were fed a diet low in fibre (LF), a diet high in soluble fibre and a diet high in insoluble fibre in a repeated 3 × 3 cross-over design. Plasma samples were collected from the mesenteric artery and the portal vein to determine different absorption phases by 1H NMR spectroscopy-based metabonomics. Time profiles were determined for plasma levels of specific metabolites and for the absorption of these metabolites from the small intestine. The LF diet resulted in a higher betaine concentration in the blood than the two high-fibre diets (P = 0·008). This leads to higher plasma concentrations of methionine (P = 0·0028) and creatine (P = 0·020) of endogenous origin. In conclusion, the use of NMR spectroscopy for measuring nutrient uptake in the present study elucidated the relationship between betaine uptake and elevated creatine plasma concentrations.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2011
Figure 0

Table 1 Dietary ingredients (g/kg diet) of the experimental diets

Figure 1

Table 2 Chemical composition and physico-chemical properties of the experimental diets

Figure 2

Fig. 1 1H NMR spectra of plasma samples taken from the (A) portal vein and the (B) mesentery artery of a representative sow 1 h after feeding on a high-fibre insoluble diet. The spectral difference between (B) mesenteric artery and (A) portal vein plasma samples was determined by (C) subtraction. Assignments are shown in spectra A as follows (multiplicity in parenthesis): 1, formate (singlet, s); 2, α-glucose (doublet, d); 3, lactate (quartet, q); 4, creatinine (s); 5, creatine (s); 6, betaine (s); 7, β-glucose; 8, overlapping peaks for creatine (s) and creatinine (s); 9, unassigned peak (s); 10, propionate (q); 11, acetate (s); 12, alanine (d); 13, lactate (d); 14, CH2 in lipids (multiplet, m); 15, propionate (triplet); 16, isoleucine, leucine and valine region; 17, CH3 in lipids (m). ppm, Parts per million.

Figure 3

Table 3 Resonance assignments of the compounds listed in Fig. 1 and as detailed in the text

Figure 4

Fig. 2 Expanded region in the 1H NMR spectra of Fig. 1(A) from a representative plasma sample showing signals from betaine, glucose and choline. s, singlet; dd, double doublet; ppm, parts per million.

Figure 5

Fig. 3 Number of misclassifications of the mean cross-model validation and the H0 distribution of no-effect determined by permutation testing with 1000 permutations. (A) Multilevel partial least-squares discriminant analysis (PLSDA) model for all venous samples and the (B) arterial–venous difference (ΔAV) when feeding the high-fibre soluble (HFS) and high-fibre insoluble (HFI) diets. (C) Ordinary PLSDA model for all venous samples and the (D) ΔAV when feeding the HFS and HFI diets.

Figure 6

Fig. 4 Rank product (RP1/20) from multilevel partial least-squares discriminant analysis models of venous samples from comparison (A) between the high-fibre soluble and low-fibre (LF) diets, (B) between the high-fibre insoluble and LF diets and (C) between the two high-fibre diets. The nomenclature is the same as in Fig. 1: 1, formate; 2, α-glucose; 3, lactate; 5, creatine; 6, betaine; 8, creatine/creatinine; 9, unassigned peak; 10, propionate; 11, acetate; 12, alanine; 13, lactate; 14, CH2 in lipids; 15, propionate; 16, isoleucine, leucine and valine region; 17, CH3 in lipids. Only bins with an RP value below the 20 % significance limit of the RP values from the 1000 permutations have been numbered. ppm, Parts per million.

Figure 7

Fig. 5 Rank product (RP1/20) from multilevel partial least-squares discriminant analysis models of the arterial–venous difference (ΔAV) from comparison (A) between the high-fibre soluble and low-fibre (LF) diets, (B) between the high-fibre insoluble and LF diets and (C) between the two high-fibre diets. The nomenclature is the same as in Fig. 1: 2, α-glucose; 3, lactate; 5, creatine; 7, β-glucose; 8, creatine/creatinine; 10, propionate; 11, acetate; 12, alanine; 13, lactate; 15, propionate; 16, isoleucine, leucine and valine region. Only bins with an RP-value below the 20 % significance limit of the RP values from the 1000 permutations have been numbered. ppm, Parts per million.

Figure 8

Table 4 ANOVA of important bins and absorption values*

Figure 9

Table 5 Alanine and glycine portal vein concentrations, and methionine portal vein concentration and absorption*

Figure 10

Fig. 6 Plasma (A–C) betaine and (D–F) creatine venous levels for sows fed a (A, D) low-fibre diet, (B, E) high-fibre soluble diet and (C, F) high-fibre insoluble diet. The six sows are marked with different symbols (○, ●, Δ, ▲, □ and ■).

Figure 11

Fig. 7 Pathway for creatine synthesis and related transmethylation. BHMT, betaine-homocysteine methyltransferase; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; GAMT, guanidinoacetate methyltransferase.